StonvexLoading…
StonvexStonvexStonvexCore line items from CPSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $32.60M | $21.12M | $27.55M | $26.59M |
Operating Income | $443.97K | $-4.38M | $1.70M | $2.23M |
Net Income | $420.35K | $-3.14M | $1.37M | $2.13M |
EPS (Diluted) | $0.03 | $-0.22 | $0.09 | $0.15 |
Total Assets | $29.51M | $18.88M | $21.60M | $21.68M |
Total Liabilities | $4.88M | $4.36M | $4.28M | $5.97M |
Cash & Equivalents | $4.47M | $3.28M | $8.81M | $8.27M |
Free Cash Flow OCF − CapEx | $-487.02K | $-4.47M | $549.18K | $3.11M |
Shares Outstanding | 17.99M | 14.53M | 14.52M | 14.45M |